Bharat Walks Again.

India doesn’t have an orthopaedics shortage. It has an outcome problem. Two patients can walk in with the exact same knee, requiring the exact same procedure, and still leave with completely different trajectories depending on where they are treated and who is holding the instruments.

For decades, joint replacement has run on individual brilliance. Skill-heavy. Highly personal. Uneven in outcome. It does not scale cleanly, and it was never designed to.

At the centre of the attempt to change that is Ajay Bagga, MD and Country Head, South Asia, of Zimmer Biomet. His mandate is not incremental improvement. It is repetition—making outcomes behave the same way across hospitals that share almost nothing else.

Where the Nerve Sits

The idea of a “centre” no longer survives contact with reality.

Factory. Operating room. Surgeon. Those used to be separate worlds. They aren’t anymore.

“The nerve today is the power of intelligence,” Bagga says. “It is no longer confined to one place.”

It sits across planning, execution, and recovery. The patient is not at the end of the chain. The patient is inside it.

Zimmer calls this ZBEdge. In practice, it is a loop that never fully closes: plan the procedure, execute with assistance, track recovery, and feed outcomes back into the next decision.

India doesn’t provide clean conditions for such procedures. Hospital systems don’t align. Departments don’t talk. Records sit fractured across formats and ownership layers.

So the system doesn’t wait for alignment. It works inside misalignment.

“The competitive edge is not really driving a perfect data pipeline,” he says. “It’s the ability to function intelligently inside imperfect systems.”

The Trust Problem

Robotics doesn’t face rejection in India. It faces delay.

Surgeons don’t push it away. They observe it.

“They don’t need convincing,” Bagga says. “They need evidence.”

The shift is not conceptual. It is mechanical. Robotics doesn’t replace surgical judgement. It removes drift.

The plan remains human. The decision remains human. But once execution begins, something changes—the variability that exists between hands begins to compress.

Not eliminated. Stabilised.

That is the point where belief changes. Not before.

You Can Install a Robot. You Can’t Install Confidence

Tier-2 expansion is usually described as an infrastructure problem. It is not.

The machine can be installed in a day. The behaviour cannot.

Adoption moves through repetition. One case. Then another. Until the system stops feeling foreign and starts feeling inevitable.

Inside the hospital, hesitation is technical. Outside it, pressure is social.

Families arrive informed. Not uniformly. Not technically. But with comparison already built in.

They already know what exists elsewhere.

What the Economics Actually Say

India is price-sensitive, but price is not the real friction point. Utilisation is.

Hospitals don’t buy robotics for visibility. They buy it for flow.

Faster recovery reduces length of stay. Reduced stay increases bed turnover.

“Reduce the stay by a day,” Bagga says, “and the system starts behaving differently.”

That is where the model works. Not prestige. Not positioning. Throughput.

But there is a structural ceiling. Price controls compress margins. In Tier-2 and Tier-3 cities, the compression becomes operational, not theoretical. If the system cannot recover its own cost through usage, it does not expand. It pauses.

Where Policy Meets The Scalpel

Policy is no longer external to this system. It sits inside it.

Bagga points to the Production Linked Incentive (PLI) framework and the ₹10,000 crore allocation toward biopharma as directional signals for high-precision manufacturing.

But capital is not the bottleneck. Structure is.

“Medical devices require different validation infrastructure than pharma,” he notes.

Testing sites. Certification layers. Regulatory speed.

CDSCO is not background governance in this model. It is throughput architecture.

Capital builds capacity. Regulation decides velocity.

India is No Longer Just a Market

India was once described in volume terms. That language has collapsed.

“It is not just a growth market,” Bagga says. “It is a strategic innovation environment.”

The difference is pressure.

Nothing here is controlled. Everything is variable. That is the point.

Zimmer’s Global Capability Center in Bengaluru is not a support function in that context. It is exposure to uncontrolled reality. Engineering and analytics are not insulated from it—they are stress-tested by it.

If a system holds in India, it is not theoretical. It has already been broken and rebuilt under pressure.

The Data Problem Still Has to Work

Hospitals in India don’t run on unified systems. They run on partial integration, legacy layers, and inconsistent digitisation.

Waiting for interoperability is not planning. It is delay.

ZBEdge works by entering what already exists rather than replacing it. Over time, alignment improves, but it is not assumed.

Bagga points to the Ayushman Bharat Digital Mission (ABDM) as the long arc of standardisation. Future systems will be forced into alignment with it.

But the present does not operate on future compliance.

It operates on mismatch.

What All This is For

All of this structure sits on top of something much simpler.

Pain changes behaviour before systems ever do.

Joint deterioration does not only reduce mobility. It compresses life. Movement reduces. Stairs are avoided. Activity shrinks. Decisions are delayed until the condition is no longer reversible in simple terms.

Fear sits inside that delay.

When outcomes become predictable, something shifts. Fear loses weight. Surgery stops being uncertainty and starts becoming planned intervention. Recovery stops being a gamble and becomes a trajectory.

Patients walk again. Not cautiously. Normally.